Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Viable Allograft Supplemented Disc Regeneration in the Treatment of Patients With Low Back Pain With or Without Intervertebral Disc Herniation - VAST Trial

NCT03709901 is registered in ClinicalTrials.gov with VIVEX Biologics, Inc. as lead sponsor.

NCT NCT03709901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03709901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Viable Allograft Supplemented Disc Regeneration in the Treatment of Patients With Low Back Pain With or Without Intervertebral Disc Herniation - VAST Trial
Lead sponsor
VIVEX Biologics, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
August 22, 2017
Completion date
January 31, 2022
Enrollment
218 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative disc disease